Insilico Medicine, Biopharmaceuticals Strike: AI Drug Deal Heads Toward $2.5B
Insilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
Small budget tweaks can compound into big wins. Regularly review spending, reallocate funds, and align expenses with priorities to improve overall finances.
27,713 articlesInsilico Medicine and SK Biopharmaceuticals unveiled a milestone collaboration worth up to $2.5 billion to develop ne...
A leading market strategist argues the AI-led pullback is routine profit-taking after a rapid rally, with the AI infr...
A wave of billionaire fund managers are boosting Amazon bets as AI hype collides with a value play. Pershing Square, ...
Meta’s AI model outlines multiple XRP price paths for 2026, showing a base target and upside scenarios as ETF demand ...
Australia moves to empower its online safety watchdog and raise penalties for breaches of the under-16 social media b...
A wave of rental demand is lifting the Midwest as policy clarity and affordable development costs attract builders. A...
Broadcom quietly dominating chips is reshaping the AI hardware market. Here are five overlooked US stocks delivering ...
Microsoft leads a renewed sector rotation as AI momentum and stable cloud revenue lift its outlook, while Intel stumb...
Americans donated a record 617B in 2025 despite higher living costs. Individual gifts rose, bequests surged, and bill...
Gemini unveils 0% commission stock trading for eligible U.S. customers, signaling a broader push to become a comprehe...
Strategy led by Michael Saylor sold a record 3,588 BTC for $216 million, sparking debate about Bitcoin's direction. A...
NVIDIA is at the center of the AI hardware boom, fueling bets that the stock will climb to new highs by 2027. Analyst...